Evidence map›Paper›PMID 39120239›Full record

ArticleHealthcare (Basel, Switzerland)2024

Assessment of Knowledge, Attitudes, and Vaccination Practices Regarding the New RSV Vaccine among Health Professionals in Greece.

Dimitrios Papagiannis, Nikolaos Tiganis, Ourania S Kotsiou, Ioannis C Lampropoulos, Evangelos C Fradelos, Foteini Malli, Konstantinos I Gourgoulianis

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dimitrios PapagiannisPublic Health & Adults Immunization Laboratory, School of Health Sciences, Faculty of Nursing, University of Thessaly, 41110 Larissa, Greece.ORCID 0000-0001-6123-559X
Nikolaos TiganisPrimary Health Care Postgraduate Program, University of Thessaly, 41500 Larissa, Greece.
Ourania S KotsiouDepartment of Human Pathophysiology, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece.ORCID 0000-0001-5219-6971
Ioannis C LampropoulosRespiratory Disorders Laboratory, Faculty of Nursing, University of Thessaly, 41110 Larissa, Greece.ORCID 0000-0002-8956-2178
Evangelos C FradelosLaboratory of Clinical Nursing, Department of Nursing, University of Thessaly, 41500 Larissa, Greece.ORCID 0000-0003-0244-9760
Foteini MalliRespiratory Disorders Laboratory, Faculty of Nursing, University of Thessaly, 41110 Larissa, Greece.ORCID 0000-0002-7595-6715
Konstantinos I GourgoulianisDepartment of Respiratory Medicine, School of Health Sciences, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece.ORCID 0000-0001-9541-1010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The introduction of a new vaccine into immunization programs represents a significant advancement in the global effort to combat vaccine-preventable diseases. Data from the World Health Organization support that immunization prevents between 2 and 3 million deaths each year across various diseases, underscoring its pivotal role in global health. The present study aims to assess the knowledge, attitudes, and anticipated vaccination practices among health professionals in Central Greece in response to the potential introduction of new Respiratory Syncytial Virus (RSV) vaccination guidelines by the National Vaccines Committee. Among the 450 health professionals solicited for the study, 219 provided responses, yielding a response rate of approximately 55%. A substantial majority (70.3%) accurately identified the vaccine's current availability, and 62.1% were aware of the current recommendation for RSV vaccination in pregnant women. In response to whether health professionals support the inclusion of an RSV vaccine in the national vaccination program if it becomes commercially available and is recommended by the Greek National Immunization Program, general practitioners showed the most support, with an average score of 4.86 (95% CI, 4.69-5.00), followed by pediatricians at 4.76 (95% CI, 4.63-4.89), pulmonologists at 4.68 (95% CI, 4.36-5.00), and obstetricians at 4.33 (95% CI, 3.95-4.71). Concerning general opinions on vaccinations, a high level of agreement was noted among the majority of health professionals, excluding nurses. Pharmacists recorded the highest agreement, with a perfect score of 5 (CI, 5.00-5.00), followed closely by pediatricians at 4.99 (CI, 4.97-5.00), GPs at 4.95 (CI, 4.85-5.00), pulmonologists at 4.93 (CI, 4.83-5.00), obstetricians at 4.74 (CI, 4.42-5.00), and nurses at 3.80 (CI, 3.06-4.54). A tailored approach to education is needed to ensure that healthcare professionals can communicate more effectively about RSV risks and vaccination benefits, fostering a proactive stance towards disease prevention and patient care. In essence, our study underscores the importance of knowledge in shaping a compassionate and responsive healthcare environment, ready to meet the challenges of RSV head-on.

Indexed as

health professionalsrespiratory syncytial virusRSVvaccines

Identifiers

PMID39120239
PMCPMC11311648

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.